New - European Medical Journal

Continue

News

EMJ
Rheumatology
27 Apr 2015

World’s First Biosimilar Monoclonal Antibody Launched in 12 European Nations

PHYSICIANS across Europe will be provided with a cost-effective new treatment option for the management of adult and paediatric…
EMJ
Cardiology
20 Apr 2015

Saunas Take the Heat Off Heart Disease

MEN who regularly use a sauna have a significantly lower risk of cardiovascular (CV) and all-cause mortality than those who attend less frequently.
EMJ
Cardiology
20 Apr 2015

Fondaparinux the Best Option to Tackle NSTEMI?

DEATH and in-hospital bleeding in patients with non-ST-segment elevation myocardial infarction (NSTEMI) appears less likely through the use of…
EMJ
Oncology
17 Apr 2015

One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-Line Treatment Before Test Results Available

Geneva, Switzerland, 17 April 2015 — Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving…
EMJ
Respiratory
17 Apr 2015

Smokers Underestimate Risks of a Few Cigarettes

Geneva, Switzerland, 17 April 2015 — Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day…
EMJ
Dermatology
17 Apr 2015

NITID – Innovation in Skin Imaging Presented in Vienna

Madrid, April 16, 2015. DermaLumics presents NITID*, an innovative, non-invasive diagnosis tool for skin surface using Optical Coherence Tomography (OCT)…
EMJ
Oncology
17 Apr 2015

Evidence Grows That Melanoma Drugs Benefit Some Lung Cancer Patients

Geneva, Switzerland, 17 April 2015 — A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to…
EMJ
Oncology
17 Apr 2015

New Real-World Clinical Practice Study Highlights the Value of the Oncotype DX® Breast Cancer Test for Patients, Physicians and the Health Care System

Studies present results from a real-life observational study in Ireland demonstrating significant reductions in chemotherapy and resulting cost-savings when the test is used in early stage breast cancer.